This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
Journal of Hematology & Oncology Open Access 02 September 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu DH et al. A review of hematopoietic cell transplantation in China: data and trends during 2008-2016. Bone Marrow Transplant(e-pub ahead of print 24 April 2017;doi:https://doi.org/10.1038/bmt.2017.59.
Impola U, Larjo A, Salmenniemi U, Putkonen M, Itala-Remes M, Partanen J . Graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with AML. Front Immunol 2016; 7: 523.
Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH et al. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Biol Blood Marrow Transplant 2009; 15: 632–638.
Fettah A, Ozbek N, Ozguner M, Azik F, Isik P, Avci Z et al. Factors associated with bone marrow stem cell yield for pediatric allogeneic stem cell transplantation: the impact of donor characteristics. Pediatr Transplant 2017; 21,doi:https://doi.org/10.1111/petr.12841.
Kim DH, Won DI, Lee NY, Sohn SK, Suh JS, Lee KB . Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 719–728.
Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP . CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biol Blood Marrow Transplant 2007; 13: 1515–1524.
Martino M, Callea I, Condemi A, Dattola A, Irrera G, Marcuccio D et al. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF). J Clin Apher 2006; 21: 169–175.
Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008; 112: 2092–2100.
Li Y, Chang Y, Xu L, Zhang X, Huang X . Negative association of donor age with CD34(+) cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests. Chin Med J (Engl) 2014; 127: 3597–3601.
Wang YT, Zhao XY, Zhao XS, Xu LP, Zhang XH, Wang Y et al. The impact of donor characteristics on the immune cell composition of mixture allografts of granulocyte-colony-stimulating factor-mobilized marrow harvests and peripheral blood harvests. Transfusion 2015; 55: 2874–2881.
Moresi R, Tesei S, Costarelli L, Viticchi C, Stecconi R, Bernardini G et al. Age- and gender-related alterations of the number and clonogenic capacity of circulating CD34+ progenitor cells. Biogerontology 2005; 6: 185–192.
Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefrancois L . Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 2004; 20: 551–562.
Su Y, Huang X, Wang S, Min WP, Yin Z, Jevnikar AM et al. Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function. Eur J Immunol 2012; 42: 1216–1225.
Ye H, Chang Y, Zhao X, Huang X . Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation. Transpl Immunol 2011; 25: 180–186.
D'Aveni M, Rossignol J, Coman T, Sivakumaran S, Henderson S, Manzo T et al. G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease. Sci Transl Med 2015; 7: 281ra242.
Acknowledgements
This work was supported (in part) by the National Natural Science Foundation of China (Grant No. 81470342). We thank the faculty members who collected samples and analyzed flow cytometry data.
Author contributions
Y-JC designed the study and collected the data; Y-JC, L-QC and LL analyzed the data and wrote the typescript; and all authors contributed to interpretation of the data, preparing the typescript and approved the final version.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Cao, LQ., Liu, L., Xu, LP. et al. Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts. Bone Marrow Transplant 53, 108–110 (2018). https://doi.org/10.1038/bmt.2017.224
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.224
This article is cited by
-
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
Journal of Hematology & Oncology (2019)
-
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization
Leukemia (2019)
-
A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells
Leukemia (2018)